COVID-19相关视网膜微血管病变:当前证据综述
合并分析仅纳入病例对照研究,结果显示COVID-19患者发生视网膜微血管病变的可能性显著高于对照(OR 8.86,95%CI 2.54-27.53,P<.01)。OCTA显示COVID-19患者血管密度降低、黄斑无血管区增大。结论提示COVID-19相关视网膜微血管病变是重要眼部表现,可能预示未来视网膜并发症。
要点
- COVID-19患者视网膜微血管病变风险显著高于对照,OR为8.86(95%CI 2.54-27.53,P<.01)。
- OCTA可检测到COVID-19患者血管密度降低和黄斑无血管区增大。
- 视网膜微血管损伤可能早于临床可见改变,OCTA有助于早期发现。
核心结论
- COVID-19相关视网膜微血管病变是COVID-19的重要眼部表现,可能预示未来视网膜并发症。
- 这些微血管损伤可能发生于临床可见改变之前,OCTA可更早检测到。
研究设计与样本
- 系统综述与荟萃分析,全面检索PubMed和Embase数据库,纳入报告COVID-19患者视网膜血管改变的研究。
- 采用RevMan Web 3.3版进行数据分析,使用美国国立卫生研究院病例对照研究质量评估工具评价证据质量。
主要发现
- COVID-19患者发生视网膜微血管病变的可能性显著高于对照,OR为8.86(95%CI 2.54-27.53,P<.01)。
- OCTA显示COVID-19患者较对照血管密度降低、黄斑无血管区增大。
关键数值与推荐
- 视网膜微血管病变的合并OR为8.86(95%CI 2.54-27.53,P<.01),COVID-19患者高于对照。
临床怎么用
- 眼科医生应将COVID-19相关视网膜微血管病变视为该病的潜在长期后遗症并加以识别。
- 对于COVID-19患者,可考虑使用OCTA早期检测视网膜微血管损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the occurrence of retinal microvasculopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and who developed coronavirus disease (COVID-19). DESIGN: Systematic review and meta-analysis. METHODS: The Pubmed and Embase databases were comprehensively searched to identify studies that reported retina vascular changes in eyes with COVID-19. Two independent reviewers selected papers and extracted data for analysis. Data of interest were extracted and analyzed in RevMan Web versions 3.3. Quality of evidence was assessed using the National Institute of Health quality assessment tool for a case-control study. RESULTS: Thirty-one studies reporting on 1373 subjects (972 COVID-19 and 401 controls) were included. Only case-control studies were included in the pooled analysis. There was a significantly higher likelihood of retinal microvasculopathy in subjects with COVID-19 compared to controls (odds ratio [95% confidence interval], 8.86 [2.54-27.53], P < .01). Optical coherence tomography angiography (OCTA) revealed reduced vessel density and enlarged foveal avascular zone in subjects with COVID-19 compared to controls. CONCLUSIONS: The results suggested that COVID-19-related retinal microvasculopathy is a significant ocular manifestation of COVID-19 and may herald future retinal complications. These microvascular impairments might have occurred antecedent to clinically visible changes and could be detected earlier by OCTA. These findings are significant, due to the large numbers with COVID-19, and need to be recognized by ophthalmologists as a potential long-term sequalae of the disease.
引用
- Teo KY, Invernizzi A, Staurenghi G, et al. COVID-19-Related Retinal Micro-vasculopathy - A Review of Current Evidence. Am J Ophthalmol. 2021. PMID: 34587494. doi:10.1016/j.ajo.2021.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。